Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000015

Chief Medical Officer sold 2,171 shares at $26.84 ($58,270)

  • Chief Medical Officer acquired 2,171 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-03-09 Option exercise 10b5-1 +2,171 $16.00 $34,736 84,660 D
Rodman David Malcom Chief Medical Officer 2026-03-09 Sale 10b5-1 −2,171 $26.84 $58,270 82,489 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-03-09 Option exercise · Stock Option 10b5-1 −2,171 23,876 D
Open-market sales · 2,171 sh · avg $26.84 · $58,270
Loading xslF345X05/wk-form4_1773179312.xml…